Noa Holoshitz is a Cardiology physician affiliated with Columbia St. Mary's Hospital. OpenAlex indexes 23 publications with 407 citations (h-index 9).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
2350 N Lake Dr
Suite 400
Milwaukee, WI 532114528
Telephone
414-271-1633Registry record last updated 17 Jan 2014.
Industry payments
14 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Medtronic, Inc.Program year20254 payments
- ABIOMEDProgram year20254 payments
- Boston Scientific CorporationProgram year20253 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
85.3%Statin20.7%Atorvastatin Calcium66%Rosuvastatin Calcium31%Pravastatin Sodium2%Simvastatin1%Part D<11 patientsBeta blocker17.2%Metoprolol Succinate54%Carvedilol29%Metoprolol Tartrate17%Part D≥125 patients+ 15 more classes in this area
Blood & clotting
10%Factor Xa inhibitor5.9%Eliquis92%Xarelto8%Part D<11 patientsP2Y12 inhibitor2.3%Clopidogrel74%Brilinta26%Part D≥36 patients+ 1 more class in this area
Metabolism & gastrointestinal
3.4%SGLT2 inhibitor3%Jardiance88%Farxiga12%Part D<11 patientsPotassium supplement0.4%Potassium Chloride100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Current Evidence-Based Treatment of Angina With Nonobstructive Coronary Arteries (ANOCA)
Journal of the Society for Cardiovascular Angiography & Interventions
2025 - Comprehensive Management of ANOCA, Part 1—Definition, Patient Population, and Diagnosis
Journal of the American College of Cardiology
2023 - Comprehensive Management of ANOCA, Part 2—Program Development, Treatment, and Research Initiatives
Journal of the American College of Cardiology
2023
Similar KOLs
Other experts from the same institution or the same specialty.
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”